⌘K

Login Start Free

Home/Filings/4/0001062993-25-012331

4//SEC Filing

Khan Sadiq 4

Accession 0001062993-25-012331

CIK 0001860871other

View on SEC.gov Company Profile

Filed

Jun 30, 8:00 PM ET

Accepted

Jul 1, 4:49 PM ET

Size

4.9 KB

Accession

0001062993-25-012331

Insider Transaction Report

Form 4

Period: 2025-06-27

Tevogen Bio Holdings Inc.TVGN

Chief Commercial Officer

Transactions

Award
Common Stock
2025-06-27+200,000→ 1,169,618 total

Footnotes (1)

[F1]Represents a grant of restricted stock under the Tevogen Bio Holdings Inc. 2024 Omnibus Incentive Plan, which will vest ratably in three equal annual installments commencing on June 27, 2030, provided that the reporting person remains in service with the Issuer at such dates.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

Tevogen Bio Holdings Inc.

CIK 0001860871

Entity typeother

Related Parties

1

filerCIK 0002011764

Filing Metadata

Form type: 4
Filed: Jun 30, 8:00 PM ET
Accepted: Jul 1, 4:49 PM ET
Size: 4.9 KB

View on SEC.gov